Phosphatidylinositides_NNS
bind_VBP
to_TO
plasma_NN
membrane_NN
CD14_NN
and_CC
can_MD
prevent_VB
monocyte_NN
activation_NN
by_IN
bacterial_JJ
lipopolysaccharide_NN
._.

Although_IN
bacterial_JJ
lipopolysaccharides_NNS
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
and_CC
several_JJ
other_JJ
microbial_JJ
agonists_NNS
can_MD
bind_VB
to_TO
mCD14_NN
-LRB-_-LRB-
membrane_NN
CD14_NN
-RRB-_-RRB-
,_,
a_DT
cell-surface_JJ
receptor_NN
found_VBN
principally_RB
on_IN
monocytes_NNS
and_CC
neutrophils_NNS
,_,
host-derived_JJ
mCD14_NN
ligands_NNS
are_VBP
poorly_RB
defined_VBN
._.

We_PRP
report_VBP
here_RB
that_IN
phosphatidylinositol_NN
-LRB-_-LRB-
PtdIns_NN
-RRB-_-RRB-
,_,
phosphatidylinositol-4-phosphate_NN
,_,
and_CC
other_JJ
phosphatidylinositides_NNS
can_MD
bind_VB
to_TO
mCD14_NN
._.

Phosphatidylserine_NN
-LRB-_-LRB-
PS_NN
-RRB-_-RRB-
,_,
another_DT
anionic_JJ
glycerophospholipid_NN
,_,
binds_VBZ
to_TO
mCD14_NN
with_IN
lower_JJR
apparent_JJ
affinity_NN
than_IN
does_VBZ
PtdIns_NN
._.

LPS-binding_JJ
protein_NN
,_,
a_DT
lipid_NN
transfer_NN
protein_NN
found_VBN
in_IN
serum_NN
,_,
facilitates_VBZ
both_CC
PS_NN
-_:
and_CC
PtdIns-mCD14_NN
binding_NN
._.

PtdIns_NN
binding_NN
to_TO
mCD14_NN
can_MD
be_VB
blocked_VBN
by_IN
anti-CD14_JJ
monoclonal_JJ
antibodies_NNS
that_WDT
inhibit_VBP
LPS-mCD14_NN
binding_NN
,_,
and_CC
PtdIns_NN
can_MD
inhibit_VB
both_CC
LPS-mCD14_NN
binding_NN
and_CC
LPS-induced_JJ
responses_NNS
in_IN
monocytes_NNS
._.

Serum-equilibrated_JJ
PtdIns_NN
also_RB
binds_VBZ
to_TO
mCD14-expressing_JJ
cells_NNS
,_,
raising_VBG
the_DT
possibility_NN
that_IN
endogenous_JJ
PtdIns_NN
may_MD
modulate_VB
cellular_JJ
responses_NNS
to_TO
LPS_NN
and_CC
other_JJ
mCD14_NN
ligands_NNS
in_FW
vivo_FW
._.

